A total of 1,768 patients with type 2 diabetes mellitus participated in three double-blind trials to evaluate the efficacy and safety of NESINA in patients with inadequate glycemic control on diet and exercise. All three trials had a four week, single-blind, placebo run-in period followed by a 26 week randomized treatment period. Patients who failed to meet prespecified hyperglycemic goals during the 26 week treatment periods received glycemic rescue therapy. 8%) were randomized to receive NESINA 12.5 mg, NESINA 25 mg or placebo once daily. Improvements in A1C were not affected by gender, age or baseline body mass index (BMI). The mean change in body weight with NESINA was similar to placebo. 8.8%) were randomized to receive NESINA 25 mg alone, pioglitazone 30 mg alone, NESINA 12.5 mg with pioglitazone 30 mg or NESINA 25 mg with pioglitazone 30 mg once daily. Coadministration of NESINA 25 mg with pioglitazone 30 mg resulted in statistically significant improvements from baseline in A1C and FPG compared to NESINA 25 mg alone and to pioglitazone 30 mg alone (Table 4). A total of 3% of patients receiving NESINA 25 mg coadministered with pioglitazone 30 mg, 11% of those receiving NESINA 25 mg alone and 6% of those receiving pioglitazone 30 mg alone required glycemic rescue. Improvements in A1C were not affected by gender, age or baseline BMI. The mean increase in body weight was similar between pioglitazone alone and NESINA when coadministered with pioglitazone. HCl 1000 mg, 17.3% of patients receiving NESINA 12.5 mg, 22.9% of patients receiving metformin HCl 500 mg, 10.8% of patients receiving metformin HCl 1000 mg and 38.7% of patients receiving placebo required glycemic rescue. Improvements in A1C were not affected by gender, age, race or baseline BMI. The mean decrease in body weight was similar between metformin alone and NESINA when coadministered with metformin.

Healthy kidneys maintain the blood creatinine within a normal range. However, as kidney function declines, the kidneys may be unable to clear the creatinine level in the blood. Abnormally high levels of creatinine could indicate potential kidney malfunction or failure. For this reason, the doctors conduct a creatinine test (along with other tests) to determine how well your kidneys perform. Any condition that affects the function of the kidneys is likely to elevate the creatinine level in the blood. It is essential to work with your nephrologist to develop a treatment plan to address any medical issues that might be implicating your kidney function. In this article, we will look at the definition of creatinine, the test to determine the creatinine levels in the blood, ways to lower creatinine levels, and myths about lowering creatinine. Creatinine is a waste product produced mainly by muscle activities from the breakdown of the compound called creatine. Creatine is a metabolite from creatine phosphate from muscle and protein metabolism, which the body uses to supply energy to the muscles.

As the muscles use energy, the tissue that comprises the muscles break down naturally, releasing the creatinine into the bloodstream. Creatinine can build up in the blood from a high protein intake, intense workout, medication or supplement dosage, or if a person has a kidney problem. Healthy kidneys filter creatinine from the blood and excrete it from the body through urine. However, impaired kidneys couldn’t filter creatinine and other waste materials properly from the body, thereby causing waste buildup. Doctors typically use a creatinine test to determine kidney function. However, checking the presence of creatinine alone in your blood isn’t the best way to evaluate your kidney health since your creatinine level is dependent on your age, race, gender, and body size. The best way to determine your kidney function is through Glomerular Filtration Rate (GFR). GFR is a calculation of your creatinine level, age, gender, race, and weight. Your GFR number will help your doctor determine if you have kidney disease.

If your GFR number is below 60 for three months you may have kidney disease. Moreover, you may have kidney disease if your GFR number is above 60 with signs of kidney damage (presence of protein in the urine). Creatinine levels can be determined through two types of tests: a blood test and a urine test. The blood test a.k.a. A healthcare specialist will draw Glyco Care Blood Sugar Formulaglucose metabolism from a vein in your arm during this test, then send the blood samples to a lab for further analysis. Serum creatinine levels will elevate as kidney function declines. In the case where your kidney function is very low, or your muscle mass is abnormal, a creatinine clearance test becomes necessary. Your doctor may likely request a random single 24-hour urine sample, which involves collecting your urine for 24 hours. Serum creatinine is measured by milligrams (mg) of creatinine per deciliter (dL) of the blood.